John Arcaroli

Affiliated with

Research Area

Biography

John Arcaroli has not added Biography.
If you are John Arcaroli and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 23	2016

Other Publications

Article	Year
Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancer. Oncotarget\| PubMed ID: 27385211	2016
HMGB1 and LPS induce distinct patterns of gene expression and activation in neutrophils from patients with sepsis-induced acute lung injury. Intensive care medicine\| PubMed ID: 17581740	2007
Lipopolysaccharide-induced neutrophil gene expression under in vivo or in vitro conditions. Chest\| PubMed ID: 11893694	2002
Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia. Journal of leukocyte biology\| PubMed ID: 12223526	2002
Involvement of phosphatidylinositol 3-kinase gamma in neutrophil apoptosis. Cellular signalling\| PubMed ID: 12464394	2003
Evidence for extracellular superoxide dismutase as a mediator of hemorrhage-induced lung injury. American journal of physiology. Lung cellular and molecular physiology\| PubMed ID: 12618426	2003
Activation of gene expression in human neutrophils by high mobility group box 1 protein. American journal of physiology. Cell physiology\| PubMed ID: 12620891	2003
Early alterations in neutrophil activation are associated with outcome in acute lung injury. American journal of respiratory and critical care medicine\| PubMed ID: 12626346	2003
Urokinase-type plasminogen activator potentiates lipopolysaccharide-induced neutrophil activation. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 12759445	2003
Modulation of bone marrow-derived neutrophil signaling by H2O2: disparate effects on kinases, NF-kappaB, and cytokine expression. American journal of physiology. Cell physiology\| PubMed ID: 14656721	2004
Hemorrhage-induced acute lung injury is TLR-4 dependent. American journal of physiology. Regulatory, integrative and comparative physiology\| PubMed ID: 15072965	2004
Genetic polymorphisms and sepsis. Shock (Augusta, Ga.)\| PubMed ID: 16205313	2005
Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis. American journal of respiratory and critical care medicine\| PubMed ID: 16528020	2006
Association between urokinase haplotypes and outcome from infection-associated acute lung injury. Intensive care medicine\| PubMed ID: 17994220	2008
Extracellular superoxide dismutase haplotypes are associated with acute lung injury and mortality. American journal of respiratory and critical care medicine\| PubMed ID: 18948423	2009
Gene array and fluorescence in situ hybridization biomarkers of activity of saracatinib (AZD0530), a Src inhibitor, in a preclinical model of colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 20682712	2010
Identification of predictive markers of response to the MEK1/2 inhibitor selumetinib (AZD6244) in K-ras-mutated colorectal cancer. Molecular cancer therapeutics\| PubMed ID: 20923857	2010
Association between IL-32 genotypes and outcome in infection-associated acute lung injury. Critical care (London, England)\| PubMed ID: 21649914	2011
Preclinical activity of the rational combination of selumetinib (AZD6244) in combination with vorinostat in KRAS-mutant colorectal cancer models. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 22173548	2012
Similarity-based multimarker association tests for continuous traits. Annals of human genetics\| PubMed ID: 22497480	2012
Patient-derived tumour xenografts as models for oncology drug development. Nature reviews. Clinical oncology\| PubMed ID: 22508028	2012
ALDH+ tumor-initiating cells exhibiting gain in NOTCH1 gene copy number have enhanced regrowth sensitivity to a γ-secretase inhibitor and irinotecan in colorectal cancer. Molecular oncology\| PubMed ID: 22521243	2012
Common PIK3CA mutants and a novel 3' UTR mutation are associated with increased sensitivity to saracatinib. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 22553375	2012
Phase I pharmacokinetic and pharmacodynamic study of cetuximab, irinotecan and sorafenib in advanced colorectal cancer. Investigational new drugs\| PubMed ID: 22615057	2013
Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer. Neoplasia (New York, N.Y.)\| PubMed ID: 22952422	2012
Biomarker-driven trial in metastatic pancreas cancer: feasibility in a multicenter study of saracatinib, an oral Src inhibitor, in previously treated pancreatic cancer. Cancer medicine\| PubMed ID: 23342270	2012
Association of the epithelial-to-mesenchymal transition phenotype with responsiveness to the p21-activated kinase inhibitor, PF-3758309, in colon cancer models. Frontiers in pharmacology\| PubMed ID: 23543898	2013
A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins. Molecular oncology\| PubMed ID: 23607916	2013
Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 23757356	2013
hsa-miR29b, a critical downstream target of non-canonical Wnt signaling, plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expression. Biology open\| PubMed ID: 23862015	2013
A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma. Investigational new drugs\| PubMed ID: 24668033	2014
Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model. International journal of cancer\| PubMed ID: 25242168	2015
An improved high yield total synthesis and cytotoxicity study of the marine alkaloid neoamphimedine: an ATP-competitive inhibitor of topoisomerase IIα and potent anticancer agent. Marine drugs\| PubMed ID: 25244109	2014
Dual pharmacological targeting of the MAP kinase and PI3K/mTOR pathway in preclinical models of colorectal cancer. PloS one\| PubMed ID: 25401499	2014
ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/β-Catenin, Notch and PI3K/Akt Signaling Pathways. PloS one\| PubMed ID: 25950950	2015
Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer models. Frontiers in pharmacology\| PubMed ID: 26136684	2015
A NOTCH1 gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancer. International journal of cancer\| PubMed ID: 26152787	2016
Targeting the WNT Signaling Pathway in Cancer Therapeutics. The oncologist\| PubMed ID: 26306903	2015
Antitumor activity of a potent MEK inhibitor, TAK-733, against colorectal cancer cell lines and patient derived xenografts. Oncotarget\| PubMed ID: 26439693	2015
Aldehyde Dehydrogenase 1B1 as a Modulator of Pancreatic Adenocarcinoma. Pancreas\| PubMed ID: 26566217	2016
The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance. Oncotarget\| PubMed ID: 27070088	2016
Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2. Journal of the National Cancer Institute\| PubMed ID: 27634934	2017